Old Web
English
Sign In
Acemap
>
authorDetail
>
Kelsey W. Nassar
Kelsey W. Nassar
Anschutz Medical Campus
Cancer research
Melanoma
Neuroblastoma RAS viral oncogene homolog
Biology
Genome
3
Papers
52
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Targeting CDK4/6 Represents a Therapeutic Vulnerability in Acquired BRAF/MEK Inhibitor–Resistant Melanoma
2021
Molecular Cancer Therapeutics
Kelsey W. Nassar
Jennifer D. Hintzsche
Stacey M. Bagby
Veronica L. Espinoza
Christophe Langouët-Astrie
Carol M. Amato
Tugs-Saikhan Chimed
Mayumi Fujita
William A. Robinson
Aik Choon Tan
Rebecca E. Schweppe
Show All
Source
Cite
Save
Citations (0)
MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells.
2020
Cell Death and Disease
Nabanita Mukherjee
Jenette Skees
Kaleb J. Todd
Drake A. West
K. Lambert
William A. Robinson
Carol M. Amato
Kasey L. Couts
Robert Van Gullick
Morgan MacBeth
Kelsey W. Nassar
Aik Choon Tan
Zili Zhai
Mayumi Fujita
Stacey M. Bagby
Chiara R. Dart
James R. Lambert
David A. Norris
Yiqun G. Shellman
Show All
Source
Cite
Save
Citations (22)
The Mutational Landscape of Mucosal Melanoma
2019
Seminars in Cancer Biology
Kelsey W. Nassar
Aik Choon Tan
Show All
Source
Cite
Save
Citations (30)
1